PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology based on the Company’s innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology.

Biotechnology

PEP-Therapy

PEP-Therapy's headquarters in Paris, France

Antoine Prestat

Michele Marzola

Jennifer Sengenès

Didier Decaudin

Fariba Némati

Philippe Tramoy

Bernard Majoie

Bruno Giroux

Isabelle Ray-Coquard

Jean-Loup Romet Lemonne

Mario Campone

Jean Martinez

Angelita Rebollo

The Scientific Advisory Team at PEP-Therapy provides expert guidance on the development and optimization of the company's innovative Cell-Penetrating and Interfering Peptides (CP&IP) technology. They advise on research strategies, clinical trial design, and regulatory considerations to advance targeted oncology therapies.

Scientific Advisory Team

This department consists of executive roles responsible for guiding the strategic direction and management of the organization.

Leadership Group

This department focuses on advancing new drug development through research initiatives and project management.

Research and Development

This department is responsible for identifying growth opportunities and developing strategic initiatives to enhance organizational performance.

PEP-Therapy

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Group

Research and Development

Business Development

Offices

PEP-Therapy

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Group

Research and Development

Business Development

Offices

Related companies